AgomAb Therapeutics N.V. American Depositary Shares Other Current Liabilities

As of the most recent data (June 2026), AGMB shows a other current liabilities of $6.7M. Scroll down for historical charts and peer comparison views.

Tracking AGMB's other current liabilities over time shows whether AgomAb Therapeutics N.V. American Depositary Shares is scaling, shrinking, or reshaping that part of the business. The current reading is $6.7M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has AgomAb Therapeutics N.V. American Depositary Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $6.7M) with ownership activity and broader fundamentals.

AgomAb Therapeutics N.V. American Depositary Shares's other current liabilities is $6.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.